Wafik S. El-Deiry: Informative presentation by John Reagan about “MyeloMATCH”
Wafik S. El-Deiry shared on LinkedIn: .
“Very informative presentation and discussion by Dr. John Reagan, Director of Hematology and Hematological Malignancies at The Warren Alpert Medical School of Brown University, as he speaks about ‘MyeloMATCH; A Precision Medicine Initiative in a Heterogenous Malignancy (AML)’ at Legorreta Cancer Center at Brown University Cancer Biology Program meeting hosted by Robert W. Sobol Jr. this afternoon.
MyeloMatch was activated on May 16, 2024.”
Source: Wafik S. El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry made important contributions in cell death signaling and our understanding of the sensitivity of tumors to chemotherapy. El-Deiry has more than 400 peer-reviewed publications and 5 edited books.
